← All companies
BBNX
Beta Bionics, Inc.
$13.35
-0.92 -6.45%
Key statistics
from XBRL data in SEC filingsMarket cap
$601M
Revenue (TTM)
$119M
Net income (TTM)
-$73.0M
EPS (TTM)
$-1.51
P/E ratio
—
Dividend yield
—
Free cash flow
-$56.2M
Cash
$44.3M
Total assets
$292M
Gross margin
58.3%
52-week range
$8.80 – $32.71
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Jul 29, 2026
8-K
Results of operations (earnings release)
Jul 29, 2026
8-K
Shareholder vote results
May 22, 2026
8-K
Regulation FD disclosure; Other events
May 21, 2026
10-Q
Quarter ended 2026-03-31
Apr 21, 2026
8-K
Results of operations (earnings release)
Apr 21, 2026
10-K
Fiscal year ended 2025-12-31
Feb 24, 2026
8-K
Results of operations (earnings release)
Feb 17, 2026
8-K
Other events
Jan 30, 2026
8-K
Results of operations (earnings release)
Jan 8, 2026
10-Q
Quarter ended 2025-09-30
Oct 28, 2025
8-K
Results of operations (earnings release)
Oct 28, 2025
10-Q
Quarter ended 2025-06-30
Jul 29, 2025
8-K
Results of operations (earnings release)
Jul 29, 2025
8-K
Regulation FD disclosure
Jun 23, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release)
May 6, 2025
10-K/A
Fiscal year ended 2024-12-31
Mar 28, 2025
8-K
Director or officer change
Mar 27, 2025
10-K
Fiscal year ended 2024-12-31
Mar 25, 2025
8-K
Results of operations (earnings release)
Mar 25, 2025
8-K
Unregistered sale of equity; Amended charter or bylaws; Other events
Jan 31, 2025
Other filings
SCHEDULE 13G
Jul 24, 2026
4/A
Jul 2, 2026
4
Jun 30, 2026
144
Jun 29, 2026
144
Jun 26, 2026
4
Jun 25, 2026
4
Jun 25, 2026
144
Jun 24, 2026
144
Jun 24, 2026
4
Jun 5, 2026
4
Jun 5, 2026
144
Jun 4, 2026
144
Jun 4, 2026
4
Jun 3, 2026
4
Jun 3, 2026
4
Jun 3, 2026
4
Jun 3, 2026
4
Jun 3, 2026